CLINICAL_TRIALS
trial_result
· 2024-04-04
Clinical Trial Update: Tinzaparin Lead-In to Prevent the Post-Thrombotic Syndrome [Phase 4]
Summary
Phase 4 trial update on tinzaparin lead-in to prevent post-thrombotic syndrome in patients with deep vein thrombosis.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sunnybrook Health Sciences Centre | Conditions: Deep Vein Thrombosis, Post Thrombotic Syndrome | Phase 4 | Status: TERMINATED